Showing results (61-70 of 95) with videos related to
Sort By:
Pageof 10
Military Psychology : the Official Journal of the Division of Military Psychology, American Psychological Association|September 8, 2025
An evaluation of the impact of social determinants of health in military reservistsBrian A Moore, Chris Hess, Kimberly D Gomes, et al.European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancerH Bleiberg, T Conroy, B Paillot, et al.European Journal of Cancer (Oxford, England : 1990)|April 18, 2012
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?F Bonnetain, J F Bosset, J P Gerard, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2010
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)G Daugaard, I Skoneczna, N Aass, et al.The New England Journal of Medicine|January 17, 2002
Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiationH Bartelink, J C Horiot, P Poortmans, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research CouncilR de Wit, J T Roberts, P M Wilkinson, et al.Journal of the National Cancer Institute|May 26, 1999
Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working PartyL Collette, R J Sylvester, S P Stenning, et al.European Journal of Cancer (Oxford, England : 1990)|March 13, 2012
Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapyT Van der Kwast, N Al Daoud, L Collette, et al.British Journal of Cancer|October 28, 2005
Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)S D Fosså, B Paluchowska, A Horwich, et al.The British Journal of Surgery|August 13, 2009
Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgeryM den Dulk, C A M Marijnen, L Collette, et al.Pageof 10